Supporting Responsible Fatherhood Program (Fatherhood FIRE)

NCT05311592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 496

Last updated 2026-01-12

No results posted yet for this study

Summary

Montefiore Medical Center (in partnership with BronxWorks) is implementing a large-scope program to promote responsible fatherhood in the Bronx among low-income adult (18 years or older) fathers with non-custodial children (under the age of 24). The program, called HERO Dads (Healthy, Empowered, Resilient, Open Dads), will promote responsible fatherhood by enhancing relationship and anger-management skills and providing marriage education; providing skills-based parenting education, disseminating information about good parenting practices, and encouraging child support payments (in partnership with our local OCSE); and fostering economic stability by providing employment-related supports inclusive of job search, vocational skills training, job referrals, and job retention.

Conditions

  • Parenting
  • Family Relations
  • Father-Child Relations

Interventions

BEHAVIORAL

HERO Dads Program

The HERO Dads Program is a 4-week series of workshops for non-custodial fathers that focuses on improving parenting, offering job support, and financial counseling.

Sponsors & Collaborators

  • Children's Bureau - Administration for Children and Families

    collaborator OTHER
  • BronxWorks

    collaborator UNKNOWN
  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Scott Wetzler, PhD · Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2025-06-10
Completion
2025-06-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05311592 on ClinicalTrials.gov